Company intelligence / Profile preview

NOVACE

Princeton, New Jersey, USA

Ownership: Private
Development stage: Other

Overview

Novace, Inc. (also known as NOVACE Corporation) was a clinical research organization (CRO) and strategic advisory firm that provided clinical development services to the biotechnology and pharmaceutical industries. The company specialized in clinical trial management, strategic planning, and bringing products from discovery through clinical validation. It was co-founded by industry veterans including Michael G. Palfreyman and led by CEO Brad Goodwin. In 2011, the company was acquired by Theorem Clinical Research to expand its clinical development capabilities.

Industry: Contract Research Organization

Beyond the preview

Go deeper on NOVACE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NOVACE.

Explore the full profile